ACHROMATOPSIA

Clinical trials for ACHROMATOPSIA explained in plain language.

Never miss a new study

Get alerted when new ACHROMATOPSIA trials appear

Sign up with your email to follow new studies for ACHROMATOPSIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

FDA-Approved drug tested to restore vision in genetic color blindness

Disease control Terminated

This early-stage study is testing whether an existing drug called glycerol phenylbutyrate (PBA) can improve vision in people with a rare, inherited form of color blindness caused by a specific gene mutation (ATF6). Two adult patients will take the drug three times a day and have …

Matched conditions: ACHROMATOPSIA

Phase: EARLY_PHASE1 • Sponsor: Columbia University • Aim: Disease control

Last updated Mar 13, 2026 15:05 UTC

ACHROMATOPSIA

Get alerted when new ACHROMATOPSIA trials appear

FDA-Approved drug tested to restore vision in genetic color blindness